Updated:
China Medical Board
China Medical Board was established in 1914 as a Rockefeller Foundation initiative and became independent in 1928. Its founding wealth traces to John D.
China Medical Board
China Medical Board was established in 1914 as a Rockefeller Foundation initiative and became independent in 1928. Its founding wealth traces to John D. Rockefeller's oil fortune. The organization has since focused on building medical, nursing, and public health capacity in Asia. The foundation deploys capital through grants and targeted program support rather than traditional asset classes. It holds a limited partnership in Landmark Equity Partners XIV. Geographic reach centers on China and Southeast Asia, with confirmed partnerships at Peking Union Medical College and Fudan University. Program areas include health equity initiatives and leadership development. The organization maintains twelve professionals and three offices. Its endowment supports annual grant-making estimated at $10 million. In January 2025 it sponsored the Prince Mahidol Award Conference in Bangkok. It also belongs to the Council on Foundations and participates in the Atlantic Institute's Equity Initiative. Governance separates the endowment from operating decisions through a board structure that includes trustees such as Fred Zuliu Hu. This setup allows the foundation to maintain long-term grant commitments while preserving independence from the original Rockefeller entities.
General information
Firm type
Endowment / Foundation
Year founded
1914
Location
Region
North America
Country
United States
City
Cambridge
Corporate office
2 Arrow St, Cambridge, MA 02138, USA
Additional offices
Beijing, China · Bangkok, Thailand
Principals
Roger I. Glass
President
Sector focus
Frequently asked questions
Who runs investment decisions at China Medical Board?
Roger I. Glass serves as President and oversees overall direction. Day-to-day investment management is handled by Fiduciary Trust Company International.
Does China Medical Board participate in fund commitments or only direct deals?
The foundation holds a limited partnership interest in Landmark Equity Partners XIV, a secondaries vehicle. No direct company investments are recorded.
Where does the underlying wealth come from?
The endowment originated from John D. Rockefeller through the Rockefeller Foundation in 1914. The foundation became independent in 1928.
How is China Medical Board related to the Rockefeller Foundation?
CMB was created in 1914 as a Rockefeller Foundation project and separated in 1928. It retains no formal ownership ties.
What investment stages does China Medical Board typically target?
The foundation does not target venture or growth stages. Its single known commitment is to a secondaries fund focused on mature private equity positions.
Does China Medical Board maintain philanthropic structures, and how are they separated?
The entire organization functions as a grant-making foundation. Endowment returns directly support program grants in health education and policy.
Which sectors does China Medical Board explicitly avoid?
No public statement lists avoided sectors. Activity remains confined to health professional education, global health, and related policy work in Asia.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: